215 related articles for article (PubMed ID: 7513198)
1. P-glycoprotein expression and function in circulating blood cells from normal volunteers.
Klimecki WT; Futscher BW; Grogan TM; Dalton WS
Blood; 1994 May; 83(9):2451-8. PubMed ID: 7513198
[TBL] [Abstract][Full Text] [Related]
2. Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype.
Drach D; Zhao S; Drach J; Mahadevia R; Gattringer C; Huber H; Andreeff M
Blood; 1992 Dec; 80(11):2729-34. PubMed ID: 1360266
[TBL] [Abstract][Full Text] [Related]
3. Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometric assay.
Ludescher C; Hilbe W; Eisterer W; Preuss E; Huber C; Gotwald M; Hofmann J; Thaler J
J Natl Cancer Inst; 1993 Nov; 85(21):1751-8. PubMed ID: 8105101
[TBL] [Abstract][Full Text] [Related]
4. The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells.
Hitzl M; Drescher S; van der Kuip H; Schäffeler E; Fischer J; Schwab M; Eichelbaum M; Fromm MF
Pharmacogenetics; 2001 Jun; 11(4):293-8. PubMed ID: 11434506
[TBL] [Abstract][Full Text] [Related]
5. Mdr1/P-glycoprotein expression in natural killer (NK) cells enriched from peripheral or umbilical cord blood.
Wilisch A; Noller A; Handgretinger R; Weger S; Nüssler V; Niethammer D; Probst H; Gekeler V
Cancer Lett; 1993 Apr; 69(2):139-48. PubMed ID: 8098658
[TBL] [Abstract][Full Text] [Related]
6. Expression of MDR1/P glycoprotein in human sarcomas.
Vergier B; Cany L; Bonnet F; Robert J; de Mascarel A; Coindre JM
Br J Cancer; 1993 Dec; 68(6):1221-6. PubMed ID: 7903154
[TBL] [Abstract][Full Text] [Related]
7. Expression of multidrug resistance gene mdr1 mRNA in a subset of normal bone marrow cells.
Marie JP; Brophy NA; Ehsan MN; Aihara Y; Mohamed NA; Cornbleet J; Chao NJ; Sikic BI
Br J Haematol; 1992 Jun; 81(2):145-52. PubMed ID: 1353683
[TBL] [Abstract][Full Text] [Related]
8. Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes.
Chaudhary PM; Mechetner EB; Roninson IB
Blood; 1992 Dec; 80(11):2735-9. PubMed ID: 1360267
[TBL] [Abstract][Full Text] [Related]
9. P-glycoprotein expression on normal and abnormally expanded natural killer cells and inhibition of P-glycoprotein function by cyclosporin A and its analogue, PSC833.
Egashira M; Kawamata N; Sugimoto K; Kaneko T; Oshimi K
Blood; 1999 Jan; 93(2):599-606. PubMed ID: 9885221
[TBL] [Abstract][Full Text] [Related]
10. No evidence of significant activity of the multidrug resistance gene product in primary human breast cancer.
Hegewisch-Becker S; Staib F; Löning T; Pichlmeier U; Kröger N; Reymann A; Hossfeld DK
Ann Oncol; 1998 Jan; 9(1):85-93. PubMed ID: 9541688
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric assessment of human MIC2 expression in bone marrow, thymus, and peripheral blood.
Dworzak MN; Fritsch G; Buchinger P; Fleischer C; Printz D; Zellner A; Schöllhammer A; Steiner G; Ambros PF; Gadner H
Blood; 1994 Jan; 83(2):415-25. PubMed ID: 7506950
[TBL] [Abstract][Full Text] [Related]
12. Quantitative measurement of the levels of melanocortin receptor subtype 1, 2, 3 and 5 and pro-opio-melanocortin peptide gene expression in subsets of human peripheral blood leucocytes.
Andersen GN; Hägglund M; Nagaeva O; Frängsmyr L; Petrovska R; Mincheva-Nilsson L; Wikberg JE
Scand J Immunol; 2005 Mar; 61(3):279-84. PubMed ID: 15787746
[TBL] [Abstract][Full Text] [Related]
13. Quantitative expression patterns of multidrug-resistance P-glycoprotein (MDR1) and differentially spliced cystic-fibrosis transmembrane-conductance regulator mRNA transcripts in human epithelia.
Bremer S; Hoof T; Wilke M; Busche R; Scholte B; Riordan JR; Maass G; Tümmler B
Eur J Biochem; 1992 May; 206(1):137-49. PubMed ID: 1375156
[TBL] [Abstract][Full Text] [Related]
14. Circulating monoclonal B cells expressing P glycoprotein may be a reservoir of multidrug-resistant disease in multiple myeloma.
Pilarski LM; Belch AR
Blood; 1994 Feb; 83(3):724-36. PubMed ID: 7507731
[TBL] [Abstract][Full Text] [Related]
15. Expression of the DAF (CD55) and CD59 antigens during normal hematopoietic cell differentiation.
Terstappen LW; Nguyen M; Lazarus HM; Medof ME
J Leukoc Biol; 1992 Dec; 52(6):652-60. PubMed ID: 1281489
[TBL] [Abstract][Full Text] [Related]
16. MDR1 polymorphisms G2677T in exon 21 and C3435T in exon 26 fail to affect rhodamine 123 efflux in peripheral blood lymphocytes.
Oselin K; Gerloff T; Mrozikiewicz PM; Pähkla R; Roots I
Fundam Clin Pharmacol; 2003 Aug; 17(4):463-9. PubMed ID: 12914549
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction.
Noonan KE; Beck C; Holzmayer TA; Chin JE; Wunder JS; Andrulis IL; Gazdar AF; Willman CL; Griffith B; Von Hoff DD; Roninson IB
Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7160-4. PubMed ID: 1976252
[TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance activity in human lymphocytes.
Coon JS; Wang YZ; Bines SD; Markham PN; Chong AS; Gebel HM
Hum Immunol; 1991 Oct; 32(2):134-40. PubMed ID: 1720770
[TBL] [Abstract][Full Text] [Related]
19. Multidrug resistance phenotype in patients with chronic lymphocytic leukemia as detected by immunofluorescence (FACS) and northern blot analysis.
Wulf G; Kluding H; Ho AD; Doerner M; Doehner H; Manegold C; Hunstein W
Leuk Res; 1994 Jul; 18(7):475-84. PubMed ID: 7912754
[TBL] [Abstract][Full Text] [Related]
20. Multidrug resistance protein (MRP) activity in normal mature leukocytes and CD34-positive hematopoietic cells from peripheral blood.
Laupèze B; Amiot L; Payen L; Drénou B; Grosset JM; Lehne G; Fauchet R; Fardel O
Life Sci; 2001 Feb; 68(11):1323-31. PubMed ID: 11233999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
